Detalles de la búsqueda
1.
Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity.
Blood
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38635762
2.
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy.
Am J Hematol
; 99(5): 880-889, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38504387
3.
Predicting Survival for Chimeric Antigen Receptor T-Cell Therapy: A Validation of Survival Models Using Follow-Up Data From ZUMA-1.
Value Health
; 25(6): 1010-1017, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35667774
4.
Review of metastatic colorectal cancer treatment pathways and early clinical experience of trifluridine/tipiracil in the UK named patient programme.
BMC Cancer
; 20(1): 91, 2020 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32013902
5.
Real-World Outcomes with Chimeric Antigen Receptor T Cell Therapies in Large B Cell Lymphoma: A Systematic Review and Meta-Analysis.
Transplant Cell Ther
; 30(1): 77.e1-77.e15, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37890589
6.
Quality-Adjusted Time without Symptoms or Toxicity: Analysis of Axicabtagene Ciloleucel versus Standard of Care in Patients with Relapsed/Refractory Large B Cell Lymphoma.
Transplant Cell Ther
; 29(5): 335.e1-335.e8, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36646322
7.
Validity of event-free survival as a surrogate endpoint in haematological malignancy: Review of the literature and health technology assessments.
Crit Rev Oncol Hematol
; 175: 103711, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35588937
8.
Drug therapy for heart failure in older patients-what do they want?
J Geriatr Cardiol
; 12(2): 165-73, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25870620
Resultados
1 -
8
de 8
1
Próxima >
>>